Infusion Rate and Volume Kinetics for Hyperoncotic Albumine in Healthy Subjects
Status:
Completed
Trial end date:
2019-01-31
Target enrollment:
Participant gender:
Summary
Treatment with colloidal solutions has during long time been a cornerstone within intensive
care. Lately there has been a shift from synthetic colloids to natural albumine.
One of these solutions is the hyperoncotic "Albumin 20%". There are however still several
aspects of the physiological effects of hyperoncotic albumin, that are not known.
In this study the main object is to study with what rate hyperoncotic albumin should be
administered. Rapidly 30 minutes or slower 120 minutes.